Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Clincal value of FDG PET/CT in response assessment of primary thyroid lymphoma

Kunihiro Nakada, Keiichi Kamijo, Nozomu Fujimoto, Hiroki Sugie and Masayuki Sakurai
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 667;
Kunihiro Nakada
1Hokko Memorial Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiichi Kamijo
2Kaisei Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nozomu Fujimoto
3Kamijo Thyroid Clinic, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Sugie
4LSI Sapporo Clinic, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Sakurai
1Hokko Memorial Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

667

Objectives Primary thyroid lymphoma (PTL) is almost always associated with Hashimoto’s thyroiditis that accumulates FDG. This study was aimed to determine whether FDG PET/CT is valuable in assessment of therapy response in PTL.

Methods 36 patients with PTL (DLBCL 8, MALT lymphoma 28) were studied. Either or both of TgAb and TPOAb were positive in all. Clinical stage was IE in 19, IIE in 14, IIIE in 2, and IVE in 1. Radiotherapy (32-40Gy), chemotherapy (R-CHOP), and chemoradiotherapy was done in 24, 4, and 8 patients, respectively. PET/CT was performed within 4 weeks before therapy and 12-16 weeks after completion of therapy combined with neck US. Therapeutic efficacy was evaluated by varying methods. Either of the following was considered as a sign for absence of viable tumor: a) negative FDG uptake by visual assessment. b) more than 50% decrease in the SUV max compared with the pretreatment value. c) disappearance of the extremely hypo-echogenic lesion on US. Final outcome was determined by ether pathologic correlation (n=25) or comparison with other imaging modalities and clinical courses (n=11).

Results In the baseline study, all thyroid lesions were FDG avid. 2 patients showed new lesion outside of the thyroid after treatment and were defined as progressive disease. In the remaining 34 patients, visually negative FDG uptake, more than 50% decrease in the SUVmax, and disappearance of the extremely hypo-echogenic lesion on US was seen in 15, 22, and 19, respectively. Finally, viable tumor was confirmed only in 2 patients. PPV of visual analysis vs. semi-quantitative analysis vs. US for residual viable tumor were 10% vs.20% vs.13%, respectively. Every method showed NPV of 100%

Conclusions Our study suggests that both visual evaluation and semi-quantitative analysis of FDG have a limited value for response assessment of PTL probably due to co-existing Hashimoto’s thyroiditis mimicking viable tumor. Persistent thyroidal FDG uptake after therapy must be interpreted with caution.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clincal value of FDG PET/CT in response assessment of primary thyroid lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clincal value of FDG PET/CT in response assessment of primary thyroid lymphoma
Kunihiro Nakada, Keiichi Kamijo, Nozomu Fujimoto, Hiroki Sugie, Masayuki Sakurai
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 667;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clincal value of FDG PET/CT in response assessment of primary thyroid lymphoma
Kunihiro Nakada, Keiichi Kamijo, Nozomu Fujimoto, Hiroki Sugie, Masayuki Sakurai
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 667;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Association between diffuse F18-FDG thyroid uptake and thyroid dysfunction
  • Bone Scintigraphy in Complex Regional Pain Syndrome Type I: A Pictorial Review
  • Genito-urinary uptake patterns and incidental lesions on a bone scan: Case based multimodality pictorial review.
Show more General Clinical Specialties

Thyroid Cancer: 'Past, Present & Future'

  • The reliability of TSH-stimulated thyroglobulin without considering serum TSH after thyroid hormone withdrawal
  • FDG avidity of metastatic thyroid cancer correlates with the presence of BRAF mutations
Show more Thyroid Cancer: 'Past, Present & Future'

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire